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Abstract 
Metallic alloys have been introduced as biodegradable metals for various biomedical applications over the last 
decade owing to their gradual corrosion in the body, biocompatibility and superior strength compared to 
biodegradable polymers. Mg alloys possess advantageous properties that make them the most extensively studied 
biodegradable metallic material for orthopedic applications such as their low density, modulus of elasticity, close to 
that of the bone, and resorbability. Early resorption (i.e., less than 3 months) and relatively inadequate strength are 
the main challenges that hinder the use of Mg alloys for bone fixation applications. The development of resorbable 
Mg-based bone fixation hardware with superior mechanical and corrosion performance requires a thorough 
understanding of the physical and mechanical properties of Mg alloys. This paper discusses the characteristics of 
successful Mg-based skeletal fixation hardware and the possible ways to improve its properties using different 
methods such as mechanical and heat treatment processes. We also review the most recent work pertaining to Mg 
alloys and surface coatings. To this end, this paper covers (i) the properties and development of Mg alloys and 
coatings with an emphasis on the Mg-Zn-Ca-based alloys; (ii) Mg alloys fabrication techniques; and (iii) strategies 
toward achieving Mg-based, resorbable, skeletal fixation devices. 
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1. Introduction 
From 2004-2005, orthopedic trauma (fractures) 
accounted for 72% of musculoskeletal injury charges 
and it was the cause of almost one-half of all the 
disease or injury-related hospitalizations in the 
United States [1, 2], similar statistics were reported in 
2012 with more than $59.5 million in total hospital 
charges in 2011 [3, 4]. For these reported charges, 
intervention is necessary to reconstruct a damaged 
skeleton and an effective fixation hardware is needed 
to support surgically set bones during the healing 
period. Internal fixation hardware (e.g., plates, 
screws, nails and wires) is placed over or within 
bones in order to hold opposing segments of 
fractured bone still during the healing period, without 
any deformation at the fracture site [5, 6]. In addition 
to trauma, internal fixation hardware, with or without 
bone grafts, is essential for skeletal reconstructive 
surgery [7]. While beneficial, in general, it is not 
practical to remove fixation hardware after the 
reconstructed bone has healed. However, the high 
stiffness of standard of care fixation hardware, 
relative to the stiffness of the host bone, may 
subsequently result in detrimental bone stress 
shielding and/or hardware stress concentrations [8, 
9].  For children, teenagers and athletes, it is 
recommended to remove the hardware to avoid future 
bone fractures caused by unnatural loading patterns 
[10]. In addition, the fixation hardware may cause 
irritation in the adjacent soft tissue. Fixation 
hardware made of a biodegradable material that also 
offers the required stability during the healing period 
and subsequently degrades would mitigate stress 
shielding of the surrounding bone while avoiding any 
potential complications associated with a second 
fixation removal surgery [11].  
Mg alloys are the most promising biodegradable 
materials for orthopedic internal fixation hardware 
[12, 13]. The Mg alloys of interest have a low 
specific density (1.74-2.0) and modulus of elasticity 
(41-45 GPa) closer to bone (5-23 GPa for cortical 
bone) [14, 15]. Currently used metallic implant 
materials have a high modulus of elasticity (e.g., 116 
GPa for titanium Ti-6Al-4V) [14, 16]. The low 
modulus of elasticity of Mg alloys reduce the 
possibility of stress shielding associated with the use 
of stiffer metallic fixation hardware [17-19]. As a 
biocompatible material, Mg wires were used as a 
ligature for bleeding vessels more than 100 years ago 
[20]. As metallic fixation hardware, an Mg-based 
skeletal fixation plate was first used by Lambotte 
[21] in 1907. That work was followed by several 
investigations of Mg and Mg alloy bone implants. 
These devices studies showed promising properties in 
stimulating bone ingrowth and healing. Mg alloys, 
however, were abandoned for decades due to their 
undesirable degradation rate and byproducts. The fast 
degradation rate of pure Mg in a physiological 
environment results in rapid loss of mechanical 
integrity and genesis of hydrogen gas [22, 23]. The 
premature loss of mechanical integrity diminishes the 
fixation’s function. The release of hydrogen may also 
be detrimental to the healing process [24]. Moreover, 
the strength of pure Mg and the earliest studied alloys 
was not high enough and much lower when 
compared to other biocompatible metals such as 
stainless steel [16, 22].  
During the last decade, the development of Mg alloys 
useful for resorbable skeletal fixation has received 
greater attention as new approaches to providing 
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sufficient mechanical strength and useful corrosion 
(resorption) rates [25, 26]. Post-fabrication treatments 
of these alloys, such as coatings and mechanical 
treatments, have also been studied [27, 28]. 
Commercially available Mg alloys (e.g., WE43, 
AZ91 and AZ31) despite their higher mechanical 
strength and enhanced corrosion resistance, are 
generally not considered suitable for biomedical 
applications due to concerns regarding their 
biocompatibility [29-32]. In order to achieve better 
biocompatibility and slower degradation, alloying 
with elements such as Al, Zn, Zr, Sr, Mn, Ca, and 
Rare earth (RE) elements (i.e. Gd, Y, La, Ce, Nd, Pr) 
has been studied [33-40]. Amongst these alloys, Mg-
Zn-Ca alloys have received the greatest interest 
because of their excellent biocompatibility, and the 
possibility to tailor the mechanical and corrosion 
properties by changing the Zn/Ca ratio and/or heat 
treatments [15, 39, 41, 42]. 
To achieve practical Mg-based implants, it is possible 
to apply a protective coating to prevent the 
biodegradation process until a desired time point. 
Coating resorption rate and byproduct safety are 
topics of recent investigations [12, 27].  
It would be a significant breakthrough if the needed 
fixation hardware properties and geometry can be 
tailored/designed to be patient-specific [1, 43]. 
Additive manufacturing (AM) or 3D printing of 
metals has received significant attention as a 
fabrication technique to produce highly accurate and 
complex-shaped structures such as patient-specific 
fixation hardware [44]. A number of tools can be 
considered for the improvement of resorbable 
implants’ rendering. Finite element analysis (FEA) 
has been used in several studies to simulate and 
evaluate the performance of permanent fixation 
hardware [45-48]. In section 3.2., we will discuss 
different kinds of Mg coating. Also, more in-depth 
discussion of additive manufacturing of Mg alloys 
will be the subject of section 4.5. The primary 
objective of this paper is to (1) present a crisp review 
of Mg-based alloys’ design considerations for bone 
fixation applications based on the in vitro and in vivo 
performances, (2) discuss the emerging trends in the 
field of Mg fabrication, forming and post-fabrication 
treatments (e.g. coating and heat treatment) that can 
help to develop a Mg-based fixation hardware with 
enhanced biomechanical performance, (3) highlight 
the current challenges and strategies towards 
achieving Mg-based, resorbable, skeletal fixation 
devices. 
2. Mg as a resorbable material 
Bone implants have historically been made of 
metallic alloys such as stainless steel (316L SS), 
surgical grade titanium (Ti-6Al-4V) and CrCoMo 
due to their high strength, durability and 
biocompatibility [5]. The modulus of elasticity of 
these alloys (e.g., 116 GPa for Ti-6Al-4V [16]) is 
significantly higher than that for bones (5-23 GPa 
[12]). This mismatch in stiffness leads to the 
phenomenon known as stress shielding. The higher 
stiffness of the fixation device compared to bone 
causes the mechanical load to transfer away from the 
adjacent bone [49, 50]. The absence of mechanical 
loading leads to a reduction in the shielded bone mass 
and density and subsequently a loss of bone [8]. Also, 
in the areas of stress concentration where the stiffer 
fixation develops high stresses on the bone such as 
around screws, a bone fracture and subsequent 
screws pull-out is more likely. In addition to stress 
shielding, leaving metallic-based fixation inside the 
body after the healing period, causes other problems 
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such as inflammatory local reactions, possible 
infection and the inability to adapt to bone growth 
near the fixation site [11, 51]. A new approach to 
address these issues is based on the use of 
biodegradable fixation. These materials should 
provide fixation only during the healing period and 
thereafter allowing the re-establishment a normal 
stress pattern [12]. Polymers such as polyglycolic 
acid (PGA), poly-L-Lactic acid (PLLA) and 
polycaprolactone (PCL) have been developed as 
biodegradable implants [38, 52-55]. Biodegradable 
polymers have shown excellent biocompatibility and 
bioresorption properties, but their lower mechanical 
strength results in larger dimensions, which limits 
their use [53, 56-58].  
Mg is a resorbable material in the body. This means 
that the corrosion byproducts are excreted or 
integrated through natural metabolic processes [59]. 
Mg-based orthopedic fixation hardware as a 
biodegradable material can overcome the limitation 
of polymers [14]. Due to Mg alloys advantages over 
other metallic and polymeric-based bone implants 
and its resorbable nature [60], there is a driving 
interest in the biomaterial community to develop Mg-
based bone implants [61-63]. “Velox CD TM” is a CE-
approved bioresorbable Mg-based vascular closure 
device that was developed by Transluminal 
technologies [64]. Other bioresorbable Mg-based 
devices are currently in the final investigation stages 
before being available in the market for different 
biomedical applications such as ureteral stents [65], 
coronary scaffold (Biotronik Dream) [66, 67], and 
bone fixation hardware [68]. To date, the only 
commercially available Mg-based bone implant is the 
“MAGNEZIX TM” screw fabricated by Syntellix [69, 
70]. This implant is made of uncoated Mg-Y-RE-Zr 
alloy and it is approved for use in Europe for fixing 
small bones and bone fragments [71]. 
In comparison with the clinically in-use titanium-
based and polymer-based fixation hardware, bone 
implant interface strength and osseointegration of Mg 
alloys have been evaluated through micro-focus 
computed tomography, push out force and extraction 
torque tests [72, 73]. Mg implants have shown 
increased bone-implant contact, higher implant 
stability and better osseointegration when compared 
with polymer-based and titanium-based implants 
especially at long implantation periods [72, 73]. 
Standard geometries of the currently available 
fixation hardware should be considered during in vivo 
evaluations since the difference in geometry may 
affect in the load pattern following implantation. Two 
such studies of Mg-based fixation hardware were 
conducted by Chaya et al. [74, 75]. They implanted 
plates (20 × 4.5 × 1-1.5 mm) and screws (7 mm 
length and 1.75 mm shaft outer diameter) made of 
99.9% pure Mg in a New Zealand White rabbit ulna 
fracture model, as seen in Figure 1. Fracture healing 
and new bone formation were observed around the 
Mg-based fixations after 8 weeks. The hardware 
degraded at a rate of 0.4 ± 0.04 mm/year. After 16 
weeks of implantation, bend test results showed 
similar flexural loads for the Mg-fixed and the 
healthy ulnae. An in vivo study in the rabbit 
conducted by Diekmann et al. [76] investigated the 
use of biodegradable Mg-Y-RE-Zr alloy 
“MAGNEZIX” interference screws for the 
reconstruction of the anterior cruciate ligament. Mg-
based screws were implanted in the left tibiae of each 
of 18 rabbits for 4, 12 and 24 weeks. Maximum gas 
volume of 330.5 ± 83 mm3 was detected in the 
medullar cavity by the 4th week. The Mg-based 
screws showed an average degradation rate of 0.17 
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mm/year over the 24 weeks of implantation. Neither 
inflammatory reactions nor necrosis of the tendon 
were observed by histological evaluation. 
 
Fig. 1. Mg fixation plate and screws. Digital image 
showing devices prior to implantation (A). Schematic 
showing device placement with fractured ulna (B) 
(adapted from [75]). 
2.1. FEA studies towards Mg-based fixation 
hardware 
Finite element analysis can be used to calculate the 
state of stress and strain distribution through repaired 
bone and its fixation hardware. The model should 
include material and morphological properties of the 
implant, the cortical bone and the cancellous bone. 
Such analysis, in addition to predicting the safety of 
the implant, fatigue and fracture can be used to assess 
the possibility of bone fracture or resorption as the 
result of the implant [77]. This modeling approach is 
also used for design modification and optimization. It 
is desirable that the maximum Von Mises (VM) 
stress of cortical bone is lower than its maximum 
yield strength (108 MPa) for sufficient fixation 
hardware biomechanical stability [78, 79]. Mg-based 
fixation hardware should not mechanically fail while 
transferring compressive stress to the healing bone 
and should limit the interface displacement to less 
than 300 μm. To date, one study has been conducted 
by Lee et al. [79] to compare the Mg-based 
resorbable screw system in a bilateral sagittal split 
ramus osteotomy (BSSO) with titanium-based and 
polymer (Inion CPS) IN-based systems. An occlusal 
load of 132 N was applied to the model on the lower 
first molar and different fixation geometries (number 
of screws) were studied. Generally, Mg-based screws 
had a similar pattern of the VM stress distribution 
compared to that of titanium-based screws more than 
to that of IN-based screws. For example, the fixation 
with 5 Mg-based screws showed better biomedical 
stability (i.e., Max. VM stress of 99.81 MPa in the 
cortical bone and 25.38 MPa in the cancellous bone) 
than the fixation with 5 IN-based screws (i.e., Max. 
VM stress of 109.02 MPa at cortical bone and 54.72 
MPa at cancellous bone) for the advancement 
surgery. Also for setback surgery, the maximum VM 
stresses developed on the cancellous bone at all 
fixation geometries were lowest using Mg-based 
screws. This study showed promising results for the 
use of Mg-based fixation hardware just after 
implantation. However, the effect of the mechanical 
integrity loss of these devices due to degradation on 
bone immobilization during the healing period has 
never been investigated. 
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2.2. The need for patient-specific fixation 
hardware 
Conventional fixation hardware systems have been in 
use for many years and they usually provide 
satisfactory results. However, several efforts have 
been being attempted to replace conventional fixation 
hardware with custom-designed, patient-specific, 
fixation hardware to overcome existing shortcomings 
of current designs such as their unsatisfactory results 
in case of severe injuries and abnormal anatomy, and 
the possibility of postoperative complications [80, 
81]. In fixation hardware, the level and the 
distribution of stress depends on the fracture location 
as well as the geometry and the material properties of 
the hardware [1, 43]. The stress pattern in the 
hardware affects the stress profile in the surrounding 
bone and, as a result, the morphology and density of 
the bone. In addition, the patient’s age, gender and 
health status all influence bone healing. Healing time 
can be divided to three phases; inflammatory phase 
(3-7 days), the strong healing union (3-4 months), 
and remodeling up to a year [25]. In healthy adults, 
the inflammatory phase usually takes from 3 to 4 
months before the bone remodeling phase starts. 
Bone remodeling is primarily driven by the pattern of 
stress. In this period, therefore, it is necessary for the 
bone to receive a stress profile as close as possible to 
that of healthy bone. 
The healing time is longer for older patients [25]. 
Therefore, degradation time of implant should take 
healing time into consideration. The geometry of the 
implant should be designed to deliver the desired pre- 
and post-degradation levels of stiffness. In the 
beginning, the implant should be stiff enough to 
immobilize the bone. After the initial healing is 
complete, the degradation should result in a reduced 
stiffness that allows the bone to receive enough 
mechanical load to recreate the original loading 
pattern. Personalized medicine that involves a 
custom-designed implant system based on patient-
specific anatomy and patient’s case could reduce 
operating time and result in better treatment 
outcomes. 
The expected excellent outcomes of using patient-
specific fixation hardware are represented in the 
reduced complication rates, and shortened operation 
time and hospital stay. All these advantages will 
result in lower overall treatment cost. Lethaus et al. 
[82] conducted a retrospective study based on 33 
patients with skull bone defects, 17 of them 
underwent reconstruction surgery with patient-
specific implants (titanium and polyether ether 
ketone, PEEK) and were compared to 16 patients 
treated with the conventional reconstructive surgery 
(re-implantation of autogenous bone specimen). They 
found that the complication rate, rate of reoperation, 
hospital stay, and the total treatment cost were 
significantly lower for patients with the patient-
specific implants (15532.08 €/patient) compared to 
the conventional treatment method (26086.06 
€/patient). 
The development of patient-specific fixation 
hardware has historically been limited by the 
available tools and the cost of fabricating the custom-
designed fixation. Additive manufacturing (3D 
printing) has made it possible to develop the needed 
patient-specific fixation system. Based on individual 
patient data (e.g. computed tomography scan), 
perfectly fitting customized fixations are created [17]. 
More details about the additive manufacturing of Mg 
are discussed in section 4.5. 
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2.3. Corrosion of pure Mg 
In addition to low yield strength (27.5 MPa) and 
hardness (28.9 HV) [38], Mg has a very fast 
corrosion rate (e.g., 2.89 mm/year in NaCl solution) 
[13] with a corrosion potential and hydrogen 
evolution rate of -2.027 V [38] (- 1.906 V in another 
study) [42] and 56.5 mL/cm2/day [38] respectively in 
simulated body fluid (SBF). In other words, Mg is 
highly susceptible to galvanic corrosion and its 
corrosion reaction in an aqueous environment 
(physiological environment) produces Mg ions, 
hydrogen (H2) and hydroxyl group (OH). The 
hydroxyl groups quickly react with Mg ions and form 
a layer on the surface of magnesium hydroxide 
Mg(OH)2 that may convert into soluble magnesium 
chloride (MgCl2) as indicated in reactions 1 to 3 
leading to an increase in the pH value [11, 83-85]. An 
increase in the pH (exceeding 7.8) is beneficial in 
slowing down the corrosion rate due to the formation 
of a stable magnesium hydroxide Mg(OH)2 surface 
layer. However, such an increase in the pH value may 
also cause the death of tissue cells with an increase in 
the inflammatory response [11]. 
Mg + 2H2O = Mg2+ + 2(OH)- + H2  (1) 
Mg2+ + 2(OH)- = Mg(OH)2  (2) 
Mg(OH)2 + Cl- = MgCl2 + 2(OH)  (3) 
In addition, hydrogen pockets as shown in reaction 1 
are formed during corrosion in the rate of 1 mL for 
every 1 mg of Mg. This may lead to separation of 
tissue and/or tissue layers, thus causing a delay in 
bone healing at the surgical site [24]. Also, the 
evolution of hydrogen may result in Mg hydrogen 
embitterment by the ingress of hydrogen into Mg, 
leading to reduction in its ductility and load bearing 
capacity. This reduction in ductility may cause a 
brittle fracture of the Mg-based fixation hardware 
[11]. Corrosion of Mg has a dynamic interface 
between Mg surface and the body fluids and cells 
[25]. This dynamic interface is more emerged in the 
early stage of corrosion due to the change in the pH 
to basification, hydrogen emission and Mg and/or Ca 
containing corrosive surface layers [25, 86]. All these 
changes during the corrosion process dynamically 
alter the interface between Mg and the physiological 
environment. 
2.4. Cytotoxicity and animal testing 
Although the short- and long-term effects of 
introducing Mg and Mg alloys into the human body 
and their biological response on cells and tissues is 
not the focus of this monograph, they present an 
important Mg-based fixation hardware design 
consideration. A quick screening of the short-term 
biocompatibility of Mg-based alloys can be evaluated 
by cytotoxicity testing while animal testing may 
serve as a key indicator for their both short- and long-
term biocompatibility. However, the in vitro and in 
vivo toxicity effects have not been considered in 
many studies during the design of Mg-based fixation 
hardware. This leads to uncertainty and a lack of 
knowledge of the effects of several alloying and 
coating elements when implanted especially for their 
long-term effects.  
The biocompatibility characteristics of Mg alloying 
elements are different. Some elements are known to 
be toxic alone or alloyed with Mg such as Cd and Pb, 
while the biocompatibility of other elements such as 
Al, Sr, Li, Zr, Si and RE-elements is uncertain and 
has not been proven yet. Although initial studies of 
such elements may show low toxicity [87, 88], their 
long-term effects on organs or general body health 
are not well known. For example, the addition of 0.5 
wt.% Sr to a Mg-1wt.%Ca alloy was found to have a 
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low overall toxicity after an in vitro cytotoxicity 
testing with a mouse osteoblastic cell line [40]. Gu et 
al. [87] evaluated the in vitro and in vivo 
biocompatibility of as-rolled Mg-Sr (with a Sr 
content ranging from 1 to 4 wt.%) as an orthopedic 
biodegradable alloy. The as-rolled Mg-2Sr alloy 
showed grade I cytotoxicity from the in vitro cell 
experiment and an enhanced mineral density and 
thicker cortical bone around the alloy from the 
intramedullary implantation test. In addition to their 
role in enhancing Mg mechanical properties, the 
addition of 1-5 wt.% Zr and 2-5 wt.% Sr to Mg was 
found to be biocompatible in vitro and in vivo [89]. 
The in vitro biocompatibility assessment using 
osteoblast-like SaOS2 cells and MTS, and 
haemolysis tests. A higher bone mineral density 
(BMD) and bone mineral content (BMC) for the Mg-
Zr alloy from the in vivo test suggest an improved 
osteointegrative properties. Also, the observed 
increase in serum ALP activity in the implanted 
animals reflected bone-forming ability [89]. In 
another study, Gu et al. [88] investigated the in vitro 
biocompatibility (cytotoxicity and 
hemocompatibility) of nine binary Mg-1X (wt.%) 
alloys with different alloying elements (Al, Ag, In, 
Mn, Si, Sn, Y, Zn and Zr). They found that pure Mg 
control was the only group that did not show reduced 
hemolysis and adhered platelets compared to all other 
prepared binary alloys. Also, Mg-1Al, Mg-1Sn and 
Mg-1Zn were the only alloys that had no significant 
reduced cell viability to fibroblasts (L-929 and 
NIH3T3) and osteoblasts (MC3T3-E1). 
On the other hand, Mg. Ca, Zn, Mn are essential 
nutritive elements that show no cell toxicity [41, 90]. 
However, they may cause toxic effects if the body 
intake of such elements exceeds the recommended 
daily dosage. The daily allowance of Mg is 0.4-0.7 g 
and excessive Mg in the body may lead to nausea. 
Also, a higher level of Mg in serum (more than 1.05 
mmol/L) was found to cause muscular paralysis [16, 
22, 35]. The highest daily intake that can be tolerated 
by the body is for Ca (0.8-1.4 g). However, inhibited 
intestinal adsorption of essential minerals may occur 
in case of excessive Ca dose [13, 91]. While, the 
allowable daily dose for Zn and Mn are 15-17 mg 
and 4 mg, respectively. Higher levels of Zn in the 
body may hinder bone development especially at 
higher concentration while excessive Mn may result 
in neurotoxicity [13, 22, 91]. The in vitro and in vivo 
biocompatibility of a binary Mg-1wt.%Ca alloy was 
studied by Li et al. [35]. No toxicity to L-929 cells 
was observed and the viability of cells for the Mg-
1wt.%Ca alloy extraction medium was better than 
that of control. The in vivo test results showed high 
activity of osteocytes around the Mg-1wt.%Ca pins 
implanted into rabbit femoral shafts with newly 
formed bone at the third month. Zhang et al. [37] 
studied the in vitro and in vivo biocompatibility of a 
high Zn content binary Mg-6wt%Zn alloy. The hot-
extruded Mg-6wt.%Zn alloy did not show any 
toxicity to L-929 cells.  HE stained tissue (containing 
heart, liver, kidney and spleen tissues) and the 
biochemical measurements, including serum 
magnesium, serum creatinine (CREA), blood urea 
nitrogen (BUN), glutamic-pyruvic transaminase 
(GPT) and creatine kinase (CK) showed no harm to 
the vital organs and new formed bone surrounding 
the implanted rods into the femoral shaft of rabbits 
was confirmed. 
As a functional way to delay the corrosion rate of Mg 
alloys for bone fixation applications, the assessment 
of the biocompatibility of a developed coating is as 
important as that for the coated alloy. Wang et al. 
[92] studied the in vivo bone response of Mg-Zn-Ca 
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alloy rods coated with Ca-def HA implanted into 
rabbit femora. Good osteoconductivity and new bone 
formation were confirmed by histopathological 
examinations. Also, Wong, et al. [93] studied the in 
vitro and in vivo biocompatibility of a AZ91 alloy 
coated with polymeric membrane fabricated by 
polycaprolactone and dichloromethane. The in vitro 
studies indicated good cytocompatibility of eGFP and 
SaOS-2 osteoblasts with the polymer-coated alloy, 
while the in vivo test showed lower degradation rate 
for the polymer-coated alloy with higher volume of 
new bone. 
It is important to mention that the release of elements 
and metal ions is related to the alloy corrosion rate in 
the physiological environment which leads to a 
change in the pH value around the implant. Any 
change in the pH value has a negative effect on 
surrounding cell viability. Hence, controlling the 
corrosion rate is a major priority not only to maintain 
the fixation hardware mechanical integrity, but also 
to insure biocompatibility. Also, the location of the 
implant plays a significant role in determining the 
allowable limits of released elements and corrosion 
products based on their local toxicity to the cells and 
tissues adjacent to the implant. For example, the 
diffusion and transfer of the released elements and 
corrosion products is influenced by the local blood 
supply, distance between tissue and the implant, and 
the implantation time [22]. 
2.5. Characteristics of successful Mg-based 
bone fixation hardware 
In spite of the numerous advantages of Mg as a 
biomaterial, pure Mg cannot satisfy all the clinical 
requirements for internal fixation hardware due to its 
low mechanical properties and undesirable corrosion 
behavior. The required mechanical properties of Mg-
based fixation hardware can be determined by 
combining finite element analysis (FEA) studies of 
the fixation procedure and static in vitro material 
testing. These studies then identify the required 
mechanical behavior of fixation to restore the normal 
stress-strain trajectories [77, 94]. Strength higher than 
200 MPa, elongation higher than 10% and corrosion 
resistance less than 0.5 mm/year (SBF at 37ºC) have 
been suggested to be the desired characteristics for 
resorbable bone fixture [95]. Fatigue, creep, and 
stress relaxation are other important mechanical 
parameters that should be considered during the 
material selection and design of Mg-based fixation 
hardware. Also, the degradation by-products 
(especially hydrogen) should be guaranteed that are 
removed by excretion without causing any toxicity to 
the body cells locally and/or systemically [94, 96]. A 
rate of 0.02 mL/cm2/h as a tolerated level of 
hydrogen evolution in the human body has been 
proposed [97]. To this end, suitable alloying and 
coating are required. 
3. Mg alloying and fixation device coatings 
Microstructure is the key factor that affects both 
mechanical and corrosion performance of Mg-based 
biomaterials. Microstructure can be altered by 
alloying (i.e., changing the chemical composition) as 
well as mechanical or heat treatment [11]. 
Furthermore, alloying can reduce corrosion rate and 
coating the surfaces of Mg-based fixation hardware 
delays corrosion. In this section, we will discuss Mg 
alloying and fixation device coating, while 
mechanical and heat treatments will be covered in 
section 4. 
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3.1. Alloying 
Solid solution strengthening, precipitate hardening 
and grain refinement strengthening are the main 
alloying mechanisms for improving the mechanical 
properties of Mg alloys [27]. Because of the 
hexagonal-closed-packed (HCP) crystal structure and 
the atomic diameter of Mg (0.320 nm), a wide range 
of elements such as Al, Zn, Ca, Zr, Si, and Rare Earth 
elements can form solid solutions with pure Mg [12, 
13]. Numerous studies have been conducted on the 
feasibility of Mg alloying for orthopedic device 
applications by characterizing their microstructure, 
mechanical properties, corrosion behavior and 
biocompatibility using both in vitro and in vivo 
studies. Mg-Ca, Mg-RE, Mg-Zn and Mg-Zr are the 
most studied Mg-based alloying systems [14, 37, 38, 
88, 98, 99]. Alloying elements have different toxicity 
(biocompatibility) characteristics. For example, Cd 
and Pb are well known to be toxic elements alone or 
alloyed with Mg [13]. However, Ca, Sr, Zr, Mn and 
Zn alone or alloyed with Mg are shown to be 
biocompatible [13, 35, 60]. Aluminum was initially 
considered but has been found to cause 
hepatotoxicity or allergic reactions [100, 101] with 
the potential of leading to Alzheimer’s disease [102] 
and it may also cause muscle fiber damage [103]. 
The release of RE elements (e.g., yttrium) as an 
alloying element was found to cause severe 
hepatoxicity [104, 105]. Mg-Ca, Mg-Zn and Mg-Zn-
Ca have been found to be the most promising 
alloying systems because of their superior 
biocompatibility, moderate strength and corrosion 
characteristics. We will discuss more about these 
alloying systems here. For more details about other 
Mg-based alloying systems, the reader can be 
referred to [12, 13]. It is important to note that the 
presence of impurities such as Fe, Ni, Be and Cu 
reduces the strength of Mg alloys while accelerating 
their corrosion rate [106]. Impurity levels of these 
elements should be kept within the physiological 
tolerance limit (Fe: 30–50, Ni: 20–50, Be: 2–4 and 
Cu: 100–300 ppm by weight) [106, 107]. Adding 
certain alloying elements (e.g., Mn and Zn), or using 
the zone solidification method can eliminate the 
harmful effects of impurities [13]. 
3.1.1. Mg-Ca alloys 
Mg-Ca alloys have received considerable attention 
for orthopedic fixation applications. They have low 
density (1.55 g/cm3), low cost, as well as the 
beneficial role of co-releasing of Mg and Ca ions 
during bone healing and remodeling [13]. The 
addition of Ca to pure Mg also protects the Mg alloy 
from oxidation during casting. This protection is due 
to the formation of a thin dense CaO film foam on the 
surface that could prevent ignition of Mg and reduce 
molten metal surface tension [108, 109]. 
Furthermore, the addition of Ca to Mg assists in grain 
refinement, strengthening the alloy over pure Mg 
[12]. In vitro and in vivo studies have revealed that a 
mixture of Mg(OH)2 and hydroxyapatite was formed 
on the surface of Mg-Ca alloys with new formation 
of bone on this surface after 3 months of implantation 
[35]. However, the rapid degradation in the 
physiological environment is the main obstacle in 
using uncoated Mg-Ca as bone fixation hardware 
[14]. Generally, an Mg-Ca alloy with Ca content of 
less than 45 wt.% is composed of lamellar eutectic 
phases of α-Mg + Mg2Ca [39, 109, 110]. The Mg2Ca 
secondary phase has a high average melting 
temperature of 715 ℃ [111]. However, Li et al. found 
reduced corrosion resistance as the proportion of 
Mg2Ca intermetallic compound in the alloy 
microstructure increases [35]. This suggests that a Ca 
content above the solubility limit (1 wt.%) leads to 
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increased formation of the Mg2Ca intermetallic 
compound, thus, the deterioration in the Mg-Ca alloy 
corrosion resistance [12, 35]. In other words, only the 
Mg-1wt.%Ca alloy has no toxicity and degrades 
gradually enough to allow bone to heal fixated. Total 
absorption took place after 3 months of implantation 
in rabbit femoral shafts. 
3.1.2. Mg-Zn alloys 
Zinc is less corrosive than Mg and is known to 
support the immune system. It is also involved in 
various aspects of cellular metabolism [37, 91]. From 
a material viewpoint, the addition of Zn to pure Mg is 
known to improve strength due to the formation of 
the MgZn intermetallic compound and refining 
(reducing) the grain size [109, 112]. Also, the 
presence of Zn in Mg alloys mitigates the adverse 
corrosion effect of impurities such as Fe and Ni [38]. 
Koç et al. [113] studied the influence of content up to 
3 wt. % on the mechanical and corrosion properties 
of the as-cast binary Mg-Zn alloy. Mechanical 
properties and corrosion resistance were found to 
increase by increasing the content of Zn% in the 
prepared Mg-Zn alloys. ZK30 and ZK60 are two 
examples of commercial Mg-Zn based alloys with a 
Zn content of less than 5.5 wt.%. For example, the 
chemical composition of ZK30 is Mg-3wt.%Zn-
0.6wt.%Zr-0.007wt.%Fe. Zhang et al. [37] 
investigated a solution-treated and hot-extruded Mg-
6wt.%Zn alloy as a biodegradable material. The 
immersion test results showed that the hydroxyapatite 
(HA) and other Mg/Ca phosphates are the corrosion 
products of this alloy seen at the surface in SBF. The 
in vivo results showed that Mg-Zn implanted rods in 
the femoral shaft of rabbits were gradually absorbed 
at a rate of 2.32 mm/year without any harmful effects 
to vital organs.  
In comparison to the Mg-rich alloys, Zn-rich Zn-Mg 
alloys offer lower corrosion rates and reduced 
hydrogen evolution [22]. The Zn-rich alloys are 
easier and safer to fabricate due to their lower 
reactivity and lower melting points [114]. Vojtěch et 
al. [114] investigated the effect of adding 1-3 wt.% 
Mg around the eutectic point. Zn-1wt.%Mg alloy 
showed the maximum yield strength and elongation 
of 90 MPa and 2% respectively with a corrosion rate 
of less than 0.145 mm/yr. This rate is significantly 
lower than any as-cast Mg-rich alloy. Murni et al. 
[115]  evaluated the cytotoxicity of Zn-3wt.%Mg 
alloy through osteoblast cell-material interaction. 
They found that the Zn-rich alloy was not cytotoxic. 
The addition of low amount of Mn to Zn-1-
1.5wt.%Mg alloys was found to enhance their 
corrosion and mechanical properties [116]. The 
disadvantages of Zn-Mg alloys are, the limited 
ductility (elongation 0.25-2%), higher density (~7.14 
g/cm3) and higher stiffness (modulus of elasticity 
~108 GPa). Table 1 presents a quantitative 
comparison between the as-cast Mg-1wt.%Zn alloy 
and Zn-1wt.%Mg alloy as two examples of the Mg-
rich and Zn-rich alloys, respectively.  
Table 1 The physical, mechanical, corrosion and 
processing characteristics of the as-cast Mg-1wt.%Zn 
and Zn-1wt.%Mg alloys [88, 114]. 
Property 
Mg-rich (Mg-
1wt.%Zn) alloy 
Zn-rich (Zn-
1wt.%Mg) alloy 
Relative density ~1.74 ~7.14 
Modulus of elasticity 
(GPa) 
~45 ~108 
Yield Strength (MPa) 25.5 ~90 
Tensile Strength (MPa) 134 150 
Elongation (e%) 18.2 ~1.75 
Corrosion in SBF 
Fast (1.52 
mm/yr) 
Slow (~0.06 
mm/yr) 
Melting Temp. (ºC) ~650 ~420 
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3.1.3. Mg-Zn-Ca alloys 
Ternary Mg-Zn-Ca alloys have improved the 
biocompatibility and mechanical characteristics over 
pure Mg and binary Mg-Ca alloys, while lower 
density than Mg-Zn alloys and desirable anti-
bacterial properties [117, 118]. In the Mg-rich alloy, 
various phases can be produced on the grain 
boundaries that result in different degradation and 
mechanical properties; the key differentiating factor 
to this end, is the Zn/Ca atomic ratio. The eutectic 
phase α-Mg+Mg2Ca+Ca2Mg6Zn3 form when the 
Zn/Ca atomic ratio is less than 1.1-1.2 [119-121] or 
1.4 in another study [122]. Above these limits, in 
addition to the primary Mg, the lamellar eutectic 
phase α-Mg+Ca2Mg6Zn3 is observed [123]. However, 
only one study by Zander and Zumdick [124] 
reported presence of the presence of emblematic 
amount of Mg2Ca phase above these limits for the 
Mg-1.8wt.%Zn-0.6wt.%Ca alloy (Zn/Ca atomic ratio 
= 1.84). The presence of the Ca2Mg6Zn3 phase has a 
more rapid corrosion rate with better mechanical 
properties, and an increased level of the corrosion 
byproduct brucite (Mg(OH)2) and hydroxyapatite 
forms on the surface [35, 120]. This atomic ratio, as 
demonstrated by Larionova et al. [122], affects the 
interplanar distances in rapidly solidified alloys. An 
increased Zn/Ca atomic ratio leads to contraction of 
the phase lattice and a decreased value causes phase 
lattice expansion. 
The high loading of alloying elements in binary 
systems (e.g., Ca in the Mg-Ca) leads to an increased 
percentage of the precipitated intermetallic 
compounds (e.g., Mg2Ca) [60]. Similarly, the 
percentage of such compounds for the Mg-Zn-Ca 
ternary alloys increases at a high loading of Zn and 
Ca (e.g., Mg2Ca, Ca2Mg6Zn3, MgZn and MgZn2). An 
increased percentage of these intermetallic 
compounds results in higher strength accompanied by 
more rapid corrosion rates. Ca content of less than 
0.5 wt.% was found as the optimum percentage for 
grain refinement of the Mg-rich Mg-Zn-Ca-Mn 
alloys [121]. It was also reported that the addition of 
more than 1 wt.% Zn to the Mg-0.5wt.%Ca and the 
Mg-1wt.%Ca alloys significantly improves corrosion 
resistance [120, 125, 126]. However, a higher Zn 
loading above 2 to 3 wt.% causes a reduction in the 
corrosion resistance with significant deterioration 
above 5 wt.% [41, 60, 120, 125]. 
3.1.4. Mg-Zn-Ca bulk metallic glasses (BMGs) 
Mg-Zn-Ca bulk metallic glasses (BMGs) have been 
studied as an alternative biodegradable fixation 
material with superior strength and corrosion 
resistance in comparison with traditional cast Mg-Zn-
Ca alloys [118, 127]. Unlike the crystalline atomic 
structure of cast alloys, Mg-Zn-Ca glasses have 
disordered atomic (glass-like) structure [128]. The 
amorphous glassy structure is usually a result of a 
rapid cooling process where the molten alloy 
crystalline phases do not have enough time to 
nucleate and grow, as a results, the materials 
undergoes a glass transition and freeze in an 
amorphous glassy state [128, 129]. In vivo pig study 
conducted by Zberg et al. [128]  indicated good 
tissue compatibility with wound-healing process 
signs and less hydrogen evolution for the amorphous 
Mg-Zn-Ca BMG than the crystalline alloy. The cast 
rods were melt-spun into glassy ribbons of 
approximately 50 µm thickness in a helium 
atmosphere. Subsequently, a copper mold injection 
casting system was used to produce 0.5 mm thick 
Mg-Zn-Ca BMG samples in an argon atmosphere. 
The glassy (60+x)Mg-(35-x)Zn-(5)Ca alloy was 
found to be the most promising Mg-Zn-Ca BMG 
with a range of tensile strength from 675 to 894 MPa 
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and an elastic range of less than 4 percent. The main 
limitations of Mg-Zn-Ca BMGs are the limited 
processing time available before the onset of 
crystallization, small critical casting thickness of 
approximately 3 mm, and the poor formability [118, 
128, 130]. These limitations result in a difficulty in 
creating fixation devices of Mg-Zn-Ca BMGs. 
3.1.5. Quaternary Mg-Zn-Ca-X alloys 
To further tune the properties of the Mg-based 
biocompatible and resorbable alloys for bone fixation 
devices, a limited number of elements such as Mn 
and Zr can be added to Mg-Zn-Ca alloys. These 
alloying elements improve properties by 
incorporating essentially insoluble metallic impurities 
such as Fe and Ni into harmless intermetallic phases 
(e.g., AlMnFe phase in Mg-Al alloys) [12, 131]. In 
several studies, Mn (up to 1 wt.%) was added to 
different binary and ternary Mg alloys to enhance 
corrosion resistance. Bakhsheshi-Rad et al. [38] 
studied the mechanical and corrosion properties of 
various binary Mg-Ca and quaternary Mg-Ca-Zn-Mn 
alloying systems. They found that the addition of 0.5 
wt.% Mn to the Mg-2wt.%Ca-2wt.%Zn and the Mg-
2wt.%Ca-4wt.%Zn alloys enhances the mechanical 
properties and the corrosion resistance by decreasing 
the grain size to 78 μm and 59 μm, respectively. The 
small grain size provides a smoother surface, thus, 
fewer surface pits are present than in both Mg-Ca and 
Mg-Ca-Zn alloys. Also, it was found that the 
quaternary Mg-Ca-Zn-Mn alloys have reduced 
corrosion by the formation of a brucite (Mg(OH)2) 
protection than the other studied alloys. It has been 
shown that these quaternary alloys with 2 wt.% Zn 
have better mechanical and corrosion performance 
than those with 4 wt.% Zn. 
The addition of Zr to Mg-Zn-Ca alloys improves 
corrosion resistance. This effect is observed at Zr 
content of less than 0.42 wt.%. Higher concentrations 
of Zr, while improving strength due to grain refining, 
speeds corrosion [12, 60]. Qu et al. [132] developed a 
quaternary Mg-Zn-Ca-Y alloy for bone fixation. In 
their study, the alloy with Mg–2.0wt.%Zn–
0.5wt.%Ca–1.0wt.%Y chemical composition was 
implanted in rabbits to study biocompatibility for 
different durations (until 24 weeks). Low levels of 
Lymphocytes and macrophages were observed 
around the local muscle tissue during the first week 
revealing the presence of a mild inflammatory cells. 
After 2-4 weeks the inflammatory cells decreased and 
completely disappeared after 12 weeks. Also, a thin 
fibrous membrane was observed around these 
implants after 2 weeks. The fibrous membrane’s 
thickness (15-25 µm) remained within the U.S. 
ASTM-F4 implant requirements (<30 µm) for the 24-
week implantation period. When compared with pure 
Mg, this alloy has a slower degradation rate with 
desirable biocompatibility. To this end, Mg-Zn-Ca 
alloys possess the best mechanical and corrosion 
properties in addition to being biocompatible. Also, 
the addition of Mn, Zr and/or Y to Mg-Zn-Ca alloys 
was found to significantly enhance the biomechanical 
performance. The mechanical and corrosion 
properties of as-cast binary, ternary and quaternary 
Mg-Zn-Ca alloys are listed in table 2. The values of 
corrosion properties vary one study to another for 
similar alloy chemical compositions. This can be 
attributed to variation in alloy microstructure during 
preparation and the non-strict conditions of the 
conducted corrosion tests within each study.
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Table 2. The tensile properties and the in vitro electrochemical corrosion characteristics for different Mg-Ca, Mg-
Zn, Mg-Zn-Ca and Mg-Zn-Ca-Mn alloys. 
Alloy composition 
(%wt.) 
Tensile properties In vitro electrochemical corrosion characteristics (SBF) 
Ref. 
0.2% Yield 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Elong. 
(%) 
Corrosion potential 
Ecorr (µv vs. SCE) 
Current 
density icorr  
(µA/cm2) 
Calculated 
corrosion rate 
(mm/year) 
Pure Mg 27.5 97.5 7.31 -2027.4 370.7 8.47 [38] 
Mg-0.5%Caa 51 91 5.0 -1876 186 - 
[98], 
[39] 
Mg-2%Ca 47.2 115.2 3.05 -1996.8 301.7 6.84 [38] 
Mg-4%Ca 34.5 77.4 2.10 -2054.5 395.7 9.04 [38] 
Mg-1%Znb 25.5 134 18.2 -1822 67.3 1.52 [88] 
Mg-1%Znc 80 127 16 -1830 124 - [113] 
Mg-3%Znc 91 147 12 -1710 102 - [113] 
Mg-2%Zn-3%Ca 117 145 0.57 -1640 (Hank’s) 3.86 (Hank’s) - [125] 
Mg-4%Zn-
0.2%Ca- 
60 185 12.5 -1700 267 2.05 [42] 
Mg-2%Zn-2%Ca-
0.5%Mn 
78.3 168.5 7.83 -1616.6 78.3 1.78 [38] 
Mg-2%Zn-
0.5%Ca-1.2%Mnd 
72 187 9.1 -1496 57.2 - [121] 
a The tensile properties were adopted from Ref. [98], while the corrosion properties were adopted from Ref. [39]. 
b The tensile properties were deduced from Fig. 2 in Ref. [88]. 
c The tensile properties were deduced from Fig. 4 in Ref. [113]. 
d The tensile properties were deduced from Fig. 5 in Ref. [121]. 
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3.2. Coating 
Coating Mg alloys improves their corrosion 
resistance in a physiological environment [12, 25, 
133, 134]. Coating must be biocompatible and have 
high corrosion resistance to maintain the mechanical 
integrity of the fixation hardware during the initial 
bone healing period. Based on the interaction 
between the coating and the Mg alloy, coatings can 
be classified into three categories: substrate-involving 
coatings, non-substrate-involving coatings, and 
composite coatings [25]. Alkaline oxidation, 
fluoridation and micro-arc oxidation (MAO) are 
some examples of the substrate-involving coating 
techniques [25]. Gu et al. [135] performed an 
alkaline oxidation process by soaking a Mg-
1.4wt.%Ca alloy in three alkaline solutions 
(Na2HPO4, Na2CO3 and NaHCO3) for 24 h followed 
by annealing at 773 K for 12 h. The surface treated 
alloy showed an improved corrosion resistance and 
slower increase of the solution pH value, due to the 
formation of a magnesium oxide layer (MgO) of 
thickness of less than 26 μm. Lei et al. [136] 
employed an anodic electrodeposition process in a 
concentrated potassium hydroxide (KOH) solution 
followed by heat treatment in air. In this process, a 
MgO coating was produced on an Mg-5.5-
6.5wt.%Zn-1.0-1.5wt.%Ca alloy, thereby slowing the 
corrosion rate. Mousa et al. [137] used an 
anodization process with SBF as the electrolyte to 
deposit a protective apatite-like coating layer, mainly 
composed of MgO phase, on AZ31B Mg alloy. The 
anodizing voltage was found to have a significant 
effect on the coating hardness and corrosion 
resistance. 
Micro-arc oxidation (MAO), also referred to as, 
plasma electrolytic oxidation (PEO) or micro plasma 
oxidation (MPO), is one of the most studied coating 
processes due to its simplicity and the formation of a 
hard protective oxide layer on the surface leading to 
enhanced corrosion resistance. During the MAO 
process, a highly adherent ceramic oxide coating is 
formed due to partial short-term melting of the oxide 
layer caused by a high voltage plasma discharges 
[138]. One of the remarkable features of MAO 
coatings is the presence of pores and cracks on the 
coating surface. This results in higher bond strength 
between the coating and the Mg alloy substrate [96]. 
MAO coating also enhances adhesion with 
subsequent organic or polymeric coatings [139].  
While MAO coating usually shows good protection 
for a few weeks, the corrosion resistance quickly 
degrades thereafter due to the presence of surface 
pores [140, 141]. To address this limitation, one 
possible solution is controlling the process 
parameters and the electrolyte to change the 
distribution and interconnectivity of the pores [142-
144]. For example, fine pores with better corrosion 
resistance are produced at lower voltages [145]. It is 
also possible to seal the outer layer pores and cracks 
with additional layers of ceramic coatings (e.g., 
hydroxyapatite [HA]) and/or polymeric coatings [96, 
146]. Other solutions include the pretreatments using 
cerium conversion coating or increasing the thickness 
of the barrier layer [96, 147, 148].  
Calcium phosphate (Ca/P) coatings such as 
hydroxyapatite (HA) and tricalcium phosphate (TCP) 
have been used in bone implants to improve the 
biocompatibility and biological response (bone 
ingrowth) as a non-substrate-involving coating. 
These ceramic coatings also offer a biocompatible 
platform for controlled drugs elution during the 
corrosion process such as antibiotics. The crystalline 
16 
 
hydroxyapatite (HA), which is the most stable Ca/P 
compound in the human body, has been extensively 
studied as a promising Mg alloy coating [12]. Wang 
et al. [92] studied the effect of calcium-deficient 
hydroxyapatite (Ca-def HA) coating on the 
degradation behavior and bone response of a Mg-
1wt.%Ca-1wt.%Zn alloy. The samples were coated 
using a pulse electrodeposition process. The coated 
Mg alloys had a significantly slower in vivo corrosion 
rate (0.15 mm/year) compared to the uncoated 
samples (0.8 mm/year). Wang et al. [149] used a 
similar approach and showed superior corrosion 
resistance and loss of mechanical properties in the 
coated samples. In a slow strain rate test in SBF with 
extension rate of 2.16 × 10−5 mm/s until fracture, Ca-
def HA coated samples had a higher ultimate strength 
of 152 MPa than that of the uncoated samples, 144 
MPa. 10−30 μm brushite (CaHPO4-2H2O) Ca/P 
bioceramic coating of patented JDBM (Mg-Nd-Zn-
Zr) alloy showed promising results with a bonding 
strength over 10 MPa [150]. Guan et al. [151] studied 
the in vitro and in vivo degradation of uncoated and 
brushite-coated Mg-based screws made of JDBM, 
i.e., Mg-3.1wt.%Nd-0.2wt.%Zn-0.4wt.%Zr. The 
screws were implanted in the mandible of New 
Zealand White rabbits. Figure 2 shows that 
degradation through as visualized by synchrotron 
radiation X-ray microtomography. Both the in vitro 
and in vivo results showed that the uncoated and 
brushite-coated screws are biocompatible. The in vivo 
degradation rates of the coated screws after 1, 4, and 
7 months of implantation were 0.161 ± 0.075, 0.097 
± 0.013, and 0.218 ± 0.030 mm/year, respectively. 
Lichen et al. [152] prepared a composite coating by 
using micro-arc oxidation (MAO) on Mg substrates 
in an aqueous solution that included hydroxyapatite 
(HA) powder. Potentiodynamic polarization tests and 
immersion tests in SBF indicated that the specimens 
with the composite coating that were anodized in the 
HA-containing electrolyte have a better corrosion 
resistance than those anodized in the HA-free 
electrolyte. In another work, Dou et al. [153] 
prepared a porous bioceramic containing tricalcium 
phosphate (TCP) coating by MAO with different 
voltages on Mg-4.75wt.%Zn-0.55wt.%Ca alloy. The 
results indicate that the voltage have a noticeable 
influence on the thickness and corrosion properties of 
the bioactive TCP-containing MAO coating. 
 
Fig. 2. Picture of original screw model (a) and 3D reconstruction images of C-JDBM screws after 1 (b), 4 (c), and 7 
(d) months of implantation. No obvious degradation happened 1 month (b) post implantation. Slight volume loss 
was found 4 months (c) post implantation. Mg screw seriously degraded after 7 months (d) of implantation (adapted 
from [151]).
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Biodegradable polymers such as poly lactic-co-
glycolic acid (PLGA), Polylactic acid (PLLA), 
dichloromethane (DCM), and polycaprolactone 
(PCL) have also been used as a non-substrate-
involving coating [25, 154-156]. It is well known that 
a PLGA coating improves corrosion resistance and 
enables cell adhesion and organization of the attached 
cell’s cytoskeleton [154]. Li et al. [157] investigated 
the effect of sealing the surface pores of MAO-
treated pure Mg samples with a layer of PCL creating 
a composite coating. The PCL layer was deposited by 
dipping the MAO-treated samples in 4 and 7 wt.% 
PCL solution for 1 min. The samples were then 
pulled out slowly at a rate of 20 mm/min. The results 
obtained from the immersion test and the 
potentiodynamic polarization test revealed that the 
porous nature of MAO-treated Mg alloys did not by 
itself reduce corrosion resistance in Hanks' balanced 
salt solution (HBSS). However, the deposition of 
PCL onto the MAO-treated surfaces significantly 
increased the corrosion resistance. Zomorodian et al. 
[158] developed a composite coating on the AZ31 
alloy by adding nano hydroxyapatite particles and an 
antibiotic, cephalexin, to PCL. Although the addition 
of the nano hydroxyapatite particles and antibiotic 
resulted in reduced corrosion protection, the 
composite coating has enhanced biocompatibility and 
anti-bacterial functionality.  
Sheng et al. [159] prepared 
hexamethylenediaminetetrakis (methylenephosphonic 
acid) (HDTMPA) surface-modified Mg alloy samples 
via a covalent immobilization process in conjunction 
with a sequential deposition process. HDTMPA is an 
organic phosphate that as a coating is biocompatible 
and provides corrosion resistance [159]. 
Electrochemical corrosion and immersion corrosion 
results reveal that the HDTMPA-coated Mg alloy 
samples provides reduced corrosion. Razavi et al. 
[160] show that a nanostructured akermanite 
(Ca2MgSi2O7) coating improves corrosion resistance 
and the surface bioactivity of the coated Mg alloys. 
These nanostructure coatings were grown on AZ91 
Mg alloy samples through an electrophoretic 
deposition (EPD) process. Zhao et al. [161] used dual 
zirconium and oxygen ion implantation to create a 
rough, hydrophobic and ZrO2-containing surface film 
on the magnesium–calcium (Mg–Ca) and 
magnesium–strontium (Mg–Sr) alloys. Through in 
vitro weight loss measurements and electrochemical 
corrosion testing of the coated alloy samples, it was 
shown that the coating increased corrosion resistance.  
A compact fluoride conversion coating composed of 
MgO and MgF2 was applied to AZ31B alloy samples 
(Mg-3wt.%Al-1.1wt.%Zn-0.70wt.%Mn) by Yan et al 
[162]. Immersion and electrochemical test results 
showed an improved corrosion resistance for the 
coated alloy in SBF. Razavi et al. [163] combined 
micro arc oxidation (MAO) and electrophoretic 
deposition (EPD) to coat AZ91 alloy samples with 
CaMgSi2O6 nanostructured diopside. 
Electrochemical corrosion, immersion and 
compression test results showed that the diopside 
coating not only slowed down the corrosion rate, but 
also enhanced in vitro bioactivity, mechanical 
stability and cytocompatibility of the alloy. 
Zomorodian et al. [164] created a composite coating 
composed of a thin inner layer of polyetherimide 
(PEI), as an adhesion promoter between Mg substrate 
and a nanohydroxyapatite-modified PCL outer layer 
to provide corrosion protection on AZ31 alloy 
samples. Increasing the PCL concentration results in 
a better corrosion protection of the Mg alloy, while 
the presence of nanohydroxyapatite particles 
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enhances the cellular response over the coating and 
reduces the coating’s corrosion resistance. 
While a coating can control degradation timing, it 
should not undermine the stabilization function of the 
resulting implant. Tan et al. [73] used the extraction 
torque test to compare the interface strength between 
AZ31B screws and the surrounding host tissues of 
uncoated samples and samples with a Si-containing 
coating. The results were compared with those of 
surgical grade titanium (Ti6Al4V) and biodegradable 
PLLA bone fixation screws. After 4 weeks of 
implantation, the extraction torque was similar for all 
of the implanted screws (15-17 N.cm). The only 
exception was for the uncoated AZ31B screws with a 
torque of 5 N.cm. After 21 weeks of implantation, the 
extraction torque for the coated AZ31B was the 
highest (about 22 N.cm) while the PLLA screws had 
the lowest extraction torque (about 11 N.cm).  
Sanchez et al. [165] is the only study we are aware of 
that attempts to correlate in vitro and in vivo results 
obtained from different Mg alloy coating studies. We 
recommend efforts be made to set standards for in 
vitro and in vivo coated alloy sample corrosion 
testing. Some of the discussed in vitro and in vivo 
work results in this section are listed in Table 3. 
4. Manufacturing of Mg alloys 
Mg alloys can be manufactured by various methods. 
The choice of a particular method depends on many 
factors such as the targeted component properties, 
shape, dimensions, the ability to cast an alloy and the 
number of parts to be synthesized [168, 169]. About 
98% of structural applications of Mg are produced by 
casting [170]. Other processing techniques such as 
liquid infiltration, in situ processes, spray deposition 
and disintegrated melt deposition can be used to 
fabricate Mg matrix composites [171]. Mechanical 
treatment (e.g., hot rolling, hot extrusion, equal 
channel angular pressing, deep rolling, low plasticity 
burnishing), machining (e.g., polishing) and heat 
treatment (e.g., age hardening) are post processing 
methods that may enhance the mechanical and 
corrosion characteristics of Mg alloys [15, 32, 35, 
172-175]. Oxidation can be minimized during 
fabrication by using an inert gas (e.g., argon) 
especially for high temperature procedures [13, 37, 
38]. An Mg alloy powder can ignite at lower 
temperatures and, therefore, handling safety should 
carefully be planned. This section deals with 
fabrication techniques to achieve alloys with desired 
mechanical properties and corrosion performance. 
4.1. Mg Alloy Casting 
Casting is the predominant method for Mg alloys 
parts production [176]. High productivity, high 
precision, and high surface quality are some of the 
reasons these parts are prepared by casting [169]. 
From materials science point of view, casting is the 
first fabrication process that assures the formation of 
secondary phases due to complete melting and 
efficient mixing of all alloying elements. Typical 
Mg-based medical devices would be firstly cast with 
a designed chemical composition, and they can then 
undergo different kinds of post-casting processes and 
treatments to obtain the desired part shape and/or to 
improve their properties (e.g. mechanical treatment, 
heat treatment and machining) [15, 27, 41, 177, 178]. 
High pressure die casting (HPDC), as well as, gravity 
casting has been used in addition to more recent 
methods of low pressure casting, squeeze casting, 
semi-solid casting, lost foam casting and ablation 
casting [179-181]. We will discuss the most common 
casting methods in this section. 
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Table 3 The in-vitro and in-vivo corrosion characteristics and biocompatibility for different coatings created on Mg 
alloys. 
Coating type Alloy type Coating process 
In vitro electrochemical corrosion test (SBF) 
In vitro 
cytotoxicity 
In vivo corrosion test 
Ref. 
Corrosion 
potential Ecorr 
(µv vs. SCE) 
Current 
density icorr  
(µA/cm2) 
Calculated 
corrosion rate 
(mm/year) 
Tissue response 
Calculated 
corrosion rate 
(mm/year) 
Magnesium oxidea Mg-Ca 
Alkaline oxidation by 
soaking in NaHCO3 for 
24 h, then annealing at 
773 K for 12 h 
-1930 (coated) 
 
-1560 (uncoated) 
39.8 (coated) 
 
316 (uncoated) 
2.29  
(coated) 
 
13.27 (uncoated) 
No toxicity to L-929 
cells 
- - [135] 
Magnesium oxide AZ31B 
MAO in 30 g/L 
Na3PO4 at 325 V for 5 
min at 3000 Hz and 0.3 
pulse ratio 
-1150 (coated) 
 
-1300 (uncoated) 
3.09 (coated) 
 
101 (uncoated) 
0.036 (coated) 
 
2.3 (uncoated) 
- - - [166] 
Ca-def HA Mg-Zn-Ca 
Pulse electrodeposition 
at 85 °C, 20 mA/cm2 
current density, 0.5 
duty cycle for 30 min 
- - - - 
Remarkable proliferation 
of osteoblast and new 
bone formation after 
implantation into rabbit 
femora 
0.15 (coated) 
 
0.8 (uncoated) 
[167] 
Brushiteb 
(CaHPO4·2H2O) 
Mg−Nd−Zn−
Zr (extruded) 
Immersion in 0.1 M 
KF for 24 h, then in 
NaNO3 + 
Ca(H2PO4)2·H2O + 
H2O2 for 24 h 
-1590 (coated) 
 
-1600 (uncoated) 
1.17 (coated) 
 
1.57 (uncoated) 
0.253 (coated) 
 
0.337 (uncoated) 
No toxicity 
toMC3T3-E1 cells 
and bone marrow 
mesenchymal stem 
cells responded 
positively 
Newly formed bone was 
observed around screws 
and a protective layer of 
bone-like 
apatite formed after 
implantation into 
mandible bones of 
rabbits 
0.161 (coated) 
[150], 
[151] 
PLGAc 
Mg-Zn 
(extruded) 
Immersion in 4% 
PLGA powder in 
chloroform solvent 
until solvent 
evaporated  
-1360 (coated) 
 
-1460 (uncoated) 
0.097 (coated) 
 
26.7 (uncoated) 
- 
the mouse 
osteoblast-like 
MC3T3 cells could 
develop enhanced 
confluence 
on and interactions 
with the coated 
samples 
- - [154] 
HDTMPA Pure Mg 
Immersion in 10 mM 
of HDTMPA solution 
(pH 6) at 60 °C for 40 
min 
-1620 (coated) 
 
-1580 (uncoated) 
5.43 (coated) 
 
4.36 (uncoated) 
- 
CaP precipitation as 
well as osteogenic 
prompted osteoblast 
cells proliferation 
- - [159] 
Nan-diopside 
(CaMgSi2O6) 
AZ91 
MAO in NaOH + 
Na2SiO3 solution at 60 
V and 30 min, then 
EPD in (CaMgSi2O6) 
suspension at 100 V 
and 3 min 
-1480 (coated) 
 
-1600 (uncoated) 
0.11 (coated) 
 
6.31 (uncoated) 
- 
Relatively stable 
interface for 
cell 
viability/adhesion 
and slow release of 
corrosion products 
after coating. 
- - [163] 
Si-containing coatingd 
AZ31B 
(extruded) 
Acidic etching, then 
immersion in NaOH + 
Na2SiO3 + Na4P2O7 for 
120 h at 60 °C 
-1160 (coated) 
 
-1230 (uncoated) 
0.51 (coated) 
 
11.34 
(uncoated) 
0.011 (coated) 
 
0.248 (uncoated) 
Showed no systemic 
toxicity and 
sensitization.  Rank: 
0 in cytotoxicity, 
hemolytics and rank: 
<1 in irritation 
bone–implant interface 
strength of coated 
AZ31B increased with 
implantation time into 
rabbit femora 
- [73] 
a The corrosion potential and current density were deduced from Fig. 8 in Ref. [135]. 
b The in vitro corrosion and cytotoxicity test results were obtained from Ref. [150], the corrosion test was conducted in Hank’s solution. 
c The in vitro corrosion test was conducted in 0.9% NaCl solution. 
d The in vitro corrosion test was conducted in Hank’s solution. 
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High pressure die casting (HPDC) is the dominant 
method of casting Mg alloy parts [182]. There are 
two types of HPDC: hot chamber die casting and cold 
chamber die casting [170]. High productivity and 
precision, excellent surface quality, and the 
possibility of fabricating thin walls and complex 
structures are the main advantages of HPDC [182, 
183]. The main drawbacks of this method are the 
limited range of alloys available, the difficulty of heat 
treatment and the formation of pores from trapped 
gas due to the high fill-up-rate and solidification 
process [169, 184]. To minimize the effect trapped 
gas and produce less porous parts, vacuum-assisted 
die casting [170, 185, 186] and super vacuum die 
casting [187, 188] have been used. These processes 
are more costly and offer lower production rates 
[170, 185]. In the hot chamber die casting method, 
molten metal is kept in an enclosed steel crucible 
under a protective atmosphere to minimize the 
formation of harmful oxides as shown in Figure 3.a. 
[185]. The cold chamber die casting process is shown 
in Figure 3.b. [185]. In this procedure, molten Mg is 
conducted into a shot cylinder by a pump, auto-
ladling or by hand ladling. It is then injected into the 
cavity to solidify under pressure. Cold chamber 
casting has several distinct advantages such as cost 
effectiveness which minimizes the chance of a 
reaction between Mg and the die material, and air; 
fabricating large parts due to the fast injection of 
metal into the cavity; and, the production of very fine 
grains due to a rapid solidification process [170, 185, 
189]. 
Gravity casting is usually performed in sand or a 
permanent metallic molds [183]. Mg parts of up to 
1400 kg have been cast by the sand casting process 
(e.g., green sand, CO2/silicate or resin-bonded sand) 
[176, 190]. Permanent Mold Casting (PMC) has 
several advantages over sand casting such as fine 
surface, precise and consistent dimensional control 
and improved mechanical properties. However, there 
are also some limitations on the variation of the 
shapes that can be produced by permanent mold 
casting [170, 191, 192].  
Low pressure casting (LPC) is illustrated in Figure 
3.c. A typical LPC machine comprises a pressurized 
crucible with a feed tube (riser tube) running from the 
crucible to the bottom of the mold [179]. The most 
significant advantage of this method over HPDC is 
that it can create hollow structures that cannot be 
produced by HPDC [179]. However, the low pressure 
casting has some drawbacks. For example, it cannot 
produce Mg structures with wall thicknesses below 3 
mm [193]. 
1.1. Mechanical treatments 
Mechanical treatments (e.g., cold working and hot 
working processes) are secondary processing 
techniques that have been used to improve Mg alloy 
mechanical properties and corrosion characteristics. 
The mechanisms for these improvements include 
stacking faults, refining the grain size and 
introducing higher density dislocations [27]. There 
are several ways to mechanically treat Mg alloys 
such as extrusion, rolling (sheet forming), deep 
drawing and forging. Hot rolling and hot extrusion 
are the most common techniques. Hot rolling has 
been found to reduce the corrosion rate of Mg-Ca 
alloys by decreasing grain size (refining) [41]. In 
general, hot extrusion requires a larger extrusion 
ratio, smaller load, and higher speed than cold 
extrusion. The extrusion speed, temperature and load 
may significantly affect the properties of hot-
extruded Mg alloys [194].  
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Fig. 3. Schematic diagrams illustrating different types of casting methods; (a) hot chamber die casting (adapted from 
[185]); (b) cold chamber die casting (adapted from [185]); (c) low pressure casting (adapted from [179]).
Li et al. [195] studied the effects of different 
extrusion conditions on the mechanical and corrosion 
properties of a Mg–2wt.%Nd–0.2wt.%Zn alloy 
(NZ20). The alloys that were preheated and extruded 
at lower temperature had relatively lower corrosion 
rate and higher yield strength in comparison to those 
extruded at a higher temperature. In another study, Li 
et al. [35] investigated the effect of hot rolling and 
hot extrusion on the mechanical and corrosion 
performance of Mg-Ca alloys. The tensile strength 
was increased from 71.38 MPa for the as-cast Mg-
1wt.%Ca alloy to 166.7 MPa and 239.63 MPa for the 
hot-rolled and hot-extruded alloys respectively. Cha 
et al. [41] investigated the effect of hot extrusion on 
refining the grain size of pure Mg; they found that the 
grain size can be reduced to 25 µm for pure Mg and 
to 10 µm for the Mg-5wt.%Ca-1wt.%Zn alloy (grain 
size of as-cast pure Mg is around 875 µm) [175]. Cha 
et al. [41] added 1 to 5wt.%Zn to the as-cast and the 
extruded Mg-5wt.%Ca alloy. In their in vivo tests on 
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Sprague–Dawley rats, H2 bubbles were formed 
during the first week after surgery and persisted for 
12 weeks in the case of the as-cast plates. On 
contrary, no H2 bubbles were observed for the 
implanted extruded plates. These results were similar 
to in vitro Hydrogen evolution tests. In a related in 
vivo study of New Zealand-white rabbits for 24 
weeks, new bone formation was observed for an 
extruded Mg-5wt.%Ca-1wt.%Zn alloy implanted 
sample with no observation of H2 bubbles [41]. 
Deep Rolling (DR) and Low Plasticity Burnishing 
(LPB) are two of the cold working processes that 
have been performed on Mg alloys. The cold working 
leads to compressive residual stresses that improve 
the corrosion resistance by means of cracking and 
pitting prevention [1].  Denkena et al.  [196] showed 
that high subsurface residual stresses induced by 
large plastic deformations during deep rolling reduce 
the corrosion rate by a factor of approximately 100 
times for a Mg-3wt.%Ca alloy. However, excessive 
values of residual compressive stresses are not 
recommended in order to avoid workpiece surface 
deterioration and microstructural upper layer damage 
[196]. The effect of grain refinement on the AZ31 
alloy corrosion behavior as a results of different 
fabrication techniques was investigated by Wang et 
al. [172]. Squeeze casting (SC), hot rolling (HR), and 
equal channel angular pressing (ECAP) processes 
were performed on AZ31 resulting in grain sizes of 
450 µm, 15 µm and 2.5 µm, respectively. The 
degradation rates in Hank’s solution of the HR and 
ECAP prepared samples were significantly lower 
than that for the SC prepared samples, as shown in 
Figure 4. For example, the degradation rate of the SC 
prepared samples was approximately 1.56 µm/day 
while it was about 1.25 µm/day for both the HR and 
ECAP prepared samples. Ratna Sunil et al. [197] 
studied the in vitro and in vivo degradation behavior 
of AZ31 alloy processed by ECAP at 300 °C for up 
to four passes. The grain size was reduced from 46 
µm to 1-5 µm after the ECAP process and the alloy 
samples processed for 4 passes showed the lowest 
corrosion rates of approximately 6mm/year after 27 h 
of in vitro immersion and 1.1 mm/year after 60 days 
of in vivo implantation. Zhang et al. [198] 
investigated the in vitro corrosion behavior of 
biomedical Mg–Zn–Ca alloy produced by high 
pressure torsion (HPT) up to 5 revolutions at room 
temperature and 7.5 GPa. It was observed that the 
HPT process caused grain refinement from 11 µm to 
130-150 nm and a uniform distribution of the 
secondary phase. These microstructural variations 
resulted in a uniform corrosion rate and mode. 
 
Fig. 4. Degradation rate in Hank's solution of the 
three material states investigated (adapted from 
[172]). 
1.2. Heat treatment 
Heat treatment involves heating and cooling of Mg 
alloy part in its solid state, normally to extreme 
temperatures and at various heating/cooling times 
and rates, to obtain enhanced mechanical and 
corrosion properties. Heat treatment of Mg alloys 
includes different processes such as solution 
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treatment, annealing, quenching and age hardening 
(precipitation hardening) [15, 177]. If final Mg alloy 
parts have complex shapes such as porous structures, 
it may not be possible to perform mechanical 
treatment. In these cases, heat treatment may be used 
to strengthen final parts by means of intermetallic 
precipitation. The production of alloy microstructures 
containing uniform fine dispersions of thermally 
stable intermetallic precipitates is a practical 
approach for enhancing Mg alloys’ strength, creep 
and corrosion resistance [177]. For example, such 
microstructures can be obtained for Mg-Ca-Al based 
alloys by mechanisms of precipitating stable eutectic 
phases such as Al2Ca [177, 199]. 
The degradation behavior of heat-treated and 
untreated die-cast AZ63 alloy (Mg–5.9wt.%Al–
3.5wt.%Zn–0.18wt.%Mn) after 14 days immersion in 
SBF was studied by Liu et al. [32]. They found that 
the corrosion rate of the solution treated (at 413 °C 
for 24 h) then age hardened (at 216 °C for 5.5 h) 
AZ63 alloy is approximately half of the untreated 
alloy. In another study, the heat-treated Mg-2Mn-
xCa (x = 0.8, 1.0, 1.2 wt.%) alloys that were solution-
treated and age-hardened showed superior 
mechanical and corrosion properties than the as-cast 
alloys [200]. This can be attributed to the 
transformation of the Mg2Ca and α-Mn phases into 
dispersed fine precipitated phases. However, for 
some other Mg alloys, heat treatment may result in 
lower corrosion resistance in chloride solutions [12, 
201].  
Age hardening (precipitation hardening) of Mg-Ca 
alloys can be enhanced by the addition of elements 
such as Al and Zn [177, 199]. New Mg-Zn-Ca alloy 
enhanced mechanical properties after age hardening 
are due to the refinement and uniform distribution of 
the α-Mg+Ca2Mg6Zn3 eutectic phase into fine 
dispersions. However, excess presence of Ca2Mg6Zn3 
phase in Mg-Zn-Ca alloys, due to the high loading of 
Zn, suppresses the formation of finely dispersed 
monolayer Guinier-Preston (G.P.) zones on basal 
planes (0001) of the Mg hexagonal-closed-packed 
(HCP) unit cell. This leads to less age hardening 
effect [15, 120]. G.P. zones in Mg-Zn-Ca alloys are 
extremely fine (less than 10 nm) Zn and/or Ca 
enriched solute regions that form during age 
hardening [15]. The presence of G.P. zones result in 
physical obstructions to the motion of dislocations 
leading to improved mechanical properties [202]. The 
atomic ratio of Ca:Zn resulting in the formation of  
these ordered G.P. zones are between 1:1 and 1:2 
[15]. Nie and Muddle [177] heat treated Mg-
1wt.%Ca-1wt.%Zn (Zn/Ca = 0.61) alloy by water 
quenching from 470 ºC, then aging in an oil bath at 
200 ºC for different aging durations. The maximum 
hardness achieved for the alloy was measured as 63 
Vickers hardness (HV) for an aging time of 2 hours.  
Mg-1wt.%Ca-1wt.%Zn was alloyed by casting, 
annealed for 5 hours at 315 ºC and solution treated 
for 24 hours at 480 ºC [203]. The alloy was then 
quenched in water (70 ºC), and finally age hardened 
in an oil bath at 200 ºC for different durations. The 
alloy aged in oil for 2 hours had the peak hardness, 
yield strength (YS) and ultimate tensile strength 
(UTS) of 63 HV, 131 MPa and 173 MPa 
respectively, with enhanced creep properties [203]. 
Bettles et al. [204] studied the effect of age hardening 
on the mechanical properties (i.e., tensile strength 
and creep) of Mg-0.1wt.%Ca-4wt.%Zn (Zn/Ca = 
24.5). The alloy was solution treated at 618 K for 8 
hours, then ramped over 2 hours to 732 K, with an 
immediate cold water quenching, then aged in oil 
bath at 450 K. The YS of this age-hardened alloy was 
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135 MPa with UTS of 263 MPa and 11% elongation. 
The precipitation hardening of Mg-0.3Ca-0.3Zn in 
atomic % (at.%) alloy of as-cast alloy samples was 
done by solution treatment at 773 K for 2 hours in 
He-filled Pyrex tubing, then water quenched, and 
finally dipped in oil bath at 473 K for different 
durations [205]. The formation of a pair of basal 
precipitates with a length of 5-7 nm brought about 
enhanced alloy hardness at longer aging durations. 
The effect of the Zn% in the age hardening response 
of Mg-0.3%Ca-x%Zn (in at.%) alloy after aging in an 
oil bath at 200 ºC for different durations resulted in a 
peak hardness of 69 HV at 0.6% Zn content (Mg-
0.5wt.%Ca-1.6wt.%Zn) and 2 hours aging duration 
[15]. Lu et al. [206] studied the effect of changing the 
grain size and CaMg6Zn3 phase volume fraction of 
Mg-3wt.%Zn-0.3wt.%Ca alloy, due to solution 
treatment and quenching, on its in vitro corrosion 
resistance. They found that corrosion resistance after 
the heat treatment process and the minimum 
corrosion rate was observed in the alloy solution 
treated at 420 °C for 24 h. Table 4 shows the 
processing history and the resulting properties of Mg-
Ca, Mg-Zn and Mg-Zn-Ca alloys. The main 
parameters that controls the formation of the Mg-Zn-
Ca alloy microstructure phases are the Zn%, Ca% 
and Zn/Ca atomic ratio. Hence, the corrosion 
performance and precipitation hardening are also 
significantly affected by these parameters.  
 
Table 4. The processing history, mechanical properties and corrosion rate of Mg-Ca, Mg-Zn and Mg-Zn-Ca alloys. 
Alloy 
composition 
(%wt.) 
Processing history 
0.2% Yield 
strength 
(MPa) 
Tensile 
strength 
(MPa) 
Elong. 
(%) 
In vitro 
electrochemical 
corrosion rate 
(mm/year) 
Ref. 
Mg-1%Ca As-cast 40 71 1.8 12.56 (SBF) [35] 
Mg-1%Ca 
Hot rolled (400 °C, 
from 5 to 2 mm) 
120 166 3 1.63 (SBF) [35] 
Mg-1%Ca 
Hot extruded (210 °C, 
17:1) 
135 239.5 10.6 1.74 (SBF) [35] 
Mg-6%Zn 
solution treated (350 
°C, 2 h) + quenched + 
Hot extruded (250 °C, 
8:1) 
169.5 279.5 18.8 0.16 (SBF) [37] 
Mg-4%Zn-
0.2%Ca 
solution treated (400 
°C, 5 h) + quenched + 
Hot extruded (270 °C, 
16:1) 
240 297 21.3 1.98 (SBF) [42] 
Mg-4%Zn-
0.1%Ca 
solution treated (618 
K, 8 h) + quenched + 
age hardened (oil, 450 
K, ~2 days) 
135 263 11 - [204] 
Mg-1%Zn-
1%Ca 
Annealed (315 °C, 5 h) 
+ solution treated (480 
°C, 24 h) + quenched 
+ age hardened (oil, 
200 °C, 2 h) 
131 173 3 - [203] 
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When Mg-Zn-Ca alloy is heat treated for use as bone 
fixation, three important factors about chemical 
composition should be considered: (i) the Ca content 
should not exceed its solubility limit (1 wt.%) in Mg 
to avoid excess formation of Mg2Ca and since further 
increase in Ca content does not cause more grain 
refinement (e.g., 0.5wt.%Ca in the Mg-Zn-Ca-Mn 
alloying system) [12, 35, 41], (ii) the Zn content 
should be below 5 wt.% since at higher Zn loading, 
corrosion resistance deteriorates [41, 60], (iii) the 
Zn/Ca atomic ratio should be in the range of 1.2 to 
2.0 since this is the range for optimum corrosion 
resistance, and age hardening effect [15, 35, 120]. 
1.3. Machining 
Different types of machining processes can be used 
with Mg alloys to reach the desired final shape, size 
and surface quality such as turning, milling, grinding 
and polishing. The surface finish quality after 
machining processes has a significant effect on the 
corrosion performance of Mg alloys [196]. Höh et al. 
[207] found that smooth surface finish reduces pitting 
corrosion and provides the best integration in bone 
compared to a rough surface finish. Yue et al. [178] 
studied the effect of surface finish after four different 
machining processes on the corrosion behavior of Mg 
ZM51/SiC composite. The employed machining 
processes were single-point diamond turning (SPDT), 
wire electrical discharge machining (WEDM), 
grinding and polishing. As seen in Figure 5, the 
surface finish quality had a significant effect on the 
Mg ZM51/SiC composite’s in vitro corrosion 
characteristics.  The highest corrosion resistance was 
observed after polishing and fine grinding. It should 
be mentioned that the use of cutting fluids during 
machining Mg components is known to reduce 
surface roughness although Mg alloys are 
traditionally machined dry [208]. 
 
 
Fig. 5. The calculated Potentiodynamic polarization test corrosion properties for various machined specimens of Mg 
ZM51/SiC composite: (a) corrosion potential (Ecorr), (b) corrosion current density (icorr). Fine grinding and polishing 
showed the highest corrosion resistance (values were deduced from [178]).
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1.4. Additive manufacturing 
Patient-specific biodegradable-metallic fixation 
hardware could reduce operating time and result in 
better treatment outcomes. It is expected that 3D 
printing (i.e., additive manufacturing or AM) of 
resorbable fixation devices will be a significant 
clinical breakthrough. AM has only recently be 
shown useful to create fixation hardware with 
controlled geometry density, surface morphology, 
mechanical properties, and corrosion rates [17]. One 
of the first efforts towards additively manufacturing 
Mg used selective laser melting (SLM) [209]. In 
SLM process, fine Mg or Mg alloy powder is 
diffused together, layer by layer, using high power 
laser beam to create a 3D Mg-based part [210]. A 
GSI Lumonics Marker SPe Nd:YAG laser was used 
with a scanning speed of 0.2-300 mm/s. Two types of 
pure Mg powder were processed: spherical grains 
(75-150 µm) and irregular-shaped grains (5-45 µm). 
Unlike coarse powders, fine powders were found to 
melt and sinter without agglomeration for energy 
densities up to 0.66 J/mm2 [211]. It was shown that 
the surface morphology and dimension characteristics 
of pure Mg specimens were affected by the laser’s 
wave mode (pulsed or continuous). Under pulsed 
mode, pulse duration was fixed at 20 ns and the 
repetition rate (frequency) varied between 10 and 60 
kHz. Increasing the pulse frequency resulted in 
further reduction in laser’s peak energy from 130 kW 
to 22 kW at 10 kHz and 60 kHz, respectively. Also, 
energy density has a significant effect on the 
presence of porosity and cracks thus, the quality of a 
SLM Mg part. Relatively smooth, flat surfaces can be 
produced by 3D printing. Depending on the energy 
density, porosity and cracks are observed. Unlike a 
pulsed laser, specimens fabricated by continuous 
wave irradiation showed a disrupted surface and 
smooth, regular beads [211]. In another study the 
mechanical properties and microstructural 
characteristics of SLM-printed Mg were investigated 
[212]. They found grain size increased as the energy 
density increased, as seen in Figure 6. This caused 
the hardness and modulus of the printed Mg to 
decrease from 0.95 to 0.59 GPa and from 33 to 27 
GPa, respectively. Savalani et al. [213] probed the 
influence of preheat and the thickness of layer in 
selective laser melting of Mg. The results showed 
that preheating improves the quality of the surface in 
conjunction with creating a better bonding to the 
surface. Also, low layer thicknesses resulted in 
smoother and flatter surfaces (low surface 
roughness). Matena et al. [214], used SLM to 
produce porous Mg implants coated with PCL to 
decrease their corrosion rate. The results showed 
reduction in the corrosion rate and good 
biocompatibility of the SLM produced magnesium 
coated with PCL. 
As expected, the success of SLM in fabricating Mg-
based implants requires overcoming the challenges 
related to powder handling. Mg alloys have a very 
high oxygen affinity. This is exacerbated in its 
powder form due to the increased surface area per 
volume. Molten Mg has a low dynamic viscosity (1.5 
Pa·s) compared to molten titanium (2.2 Pa·s). The 
small difference between Mg’s melting point (650 ºC 
for pure Mg) and vaporization point (1090 ºC for 
pure Mg) at atmospheric pressure, (ca 440 ºC for pure 
Mg), also present significant challenges for powder 
production and handling [215]. The low dynamic 
viscosity of Mg may cause spatter and porosity, and a 
further decrease in the viscosity will undermine laser-
melted Mg track formation [216]. 
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Fig. 6. Scanning electron microscopy (SEM) of Mg powder surface morphology which was processed under pulse 
wave irradiation at three energy density values (a) 1.13 × 1012 J/m2; (b) 3.27 × 1012 J/m2; (c) 9.80 × 1012 J/m2 and 
under continuous wave irradiation at three energy density values (d) 1.27 × 109 J/m2; (e) 3.92 × 109 J/m2; (f) 7.84 × 
109 J/m2 [212].
It is therefore, important to choose proper process 
parameters, so the level of the input energy and the 
melt temperature are not high. Hence, an excessive, 
problematic, decrease in dynamic viscosity can be 
avoided. The small difference between the melting 
and vaporization points results in an increased 
powder “balling” tendency. An additional adverse 
effect is in the deposition of Mg vapor on the 
surfaces of the SLM chamber [217-219]. A possible 
solution to this problem would be increasing the 
pressure of the processing chamber. At pressure of 3 
bars, the temperature difference between the melting 
point (ca 650 ºC) and the vaporization points (1220 
ºC) for pure Mg can increase from 440 ºC, at 
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atmospheric pressure, to 570 ºC as depicted in Figure 
7 [217, 220]. Using this approach, the research team 
at the Fraunhofer Institute for Laser Technology 
(ILT) has succeeded in additively manufacturing the 
commercial AZ91 alloy using SLM. The resulting 
parts have a density greater than 99 percent. During 
the process, the oxygen content of the inert gas 
atmosphere was successfully controlled below 10 
ppm to eliminate the chance of oxidation due to the 
high oxygen affinity of Mg and Mg alloys [221]. 
Roland et al. [222] succeeded to create porous Mg 
samples using SLM with highest possible resolution 
achieved of 600 µm. Similar Mg porous structures 
were fabricated by Matena et al. [214] by SLM. The 
samples were then coated with PCL and their 
biocompatibility was compared with titanium 
scaffolds fabricated by SLM and coated with PCL. 
The live cell imaging showed similar seeding 
densities for Mg and titanium samples until the 
second day. After two days, Mg samples showed 
decreased cell number. Also, the in vitro corrosion 
testing for the PCL-coated Mg samples showed 
enhanced corrosion resistance compared to non-
coated Mg samples [214]. It is also possible to 3D 
print porous Fe-Mn scaffolds using a powder based 
binder jet printing [223]. These Fe-Mn alloy 
scaffolds demonstrated good cytocompatibility 
compared to tissue culture plastic with tensile 
mechanical properties similar to natural bone and 
corroded much faster than those made of pure iron 
[224].  
Fig. 7. Schematic unary phase diagram for pure magnesium, showing the melting and vaporization points at two 
pressure levels (1 bar and 3 bar), increasing the pressure from one atmosphere pressure (1 bar) to 3 atmosphere 
pressure (3 bar) increases the difference between the melting and vaporization temperatures from 440 ºC to 570 ºC 
which results in less powder balling tendency [215, 217, 220]. 
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2. Conclusions 
Ultimately, the aim of this work is to guide 
future investigators toward developing 
successful resorbable bone fixation hardware by 
covering the topics of resorbable bone fixation 
characteristics and the progress in property 
improvements by alloying, coating, and possible 
fabrication techniques. Biodegradable alloys 
hold promise for bone fixation hardware. 
However, these biocompatible alloys, especially 
Mg alloys, with acceptable mechanical and 
corrosion properties, as well as viable fixation 
device fabrication methods, are beginning to be 
tested in experimental settings. Resorbable 
fixation that can carry the body’s load and then 
safely resorb would be a significant clinical 
breakthrough. Several Mg alloys are resorbable 
and offer promising alternatives to resorbable 
polymers due to their relatively greater strength, 
higher implant stability, and better 
osseointegration.  
The process of developing patient-specific 
biodegradable Mg fixation hardware can start 
from an FEA of the bone to be repaired and 
design of optimal fixation mechanical properties 
and geometry in early stages. Mg, Ca, Zn and 
Mn alloys are among the most resorbable and 
biocompatible metals available for these 
applications. Coatings can prevent resorption of 
an Mg alloy fixation device until the initial phase 
of bone healing is completed. The selection and 
designing of the appropriate coating that will 
resorb at a highly predictable rate, prevent 
biofilm formation, and possibly deliver 
antibiotics has yet to be identified. Other factors 
that should be considered are implantation 
location and the interaction between the coating 
and the Mg alloy substrate. Carefully designed 
comparative coating studies would be helpful. 
To this end, there is a need for standards for the 
in vivo and in vitro Mg alloy fixation device 
corrosion and mechanical tests. Another area that 
requires attention is the corrosion behavior of 
coated and heat-treated Mg alloys. Equally 
important is a more comprehensive investigation 
of 3D-printing as a fabrication technique for 
patient-specific Mg alloy fixation devices.  
Casting is the prevalent fabrication method for 
Mg alloys; HPDC is the most dominant casting 
method due to its high production rate and 
excellent surface quality. Mechanical treatments 
such as hot rolling, hot extrusion, and deep 
rolling can be used to enhance the mechanical 
and corrosion characteristics of the resulting 
parts. Heat treatment (e.g., age hardening) is an 
effective way to improve the Mg alloys 
mechanical properties as in the case of Mg-Zn-
Ca alloys. In addition to Zn and Ca contents, the 
Zn/Ca ratio significantly affect the number of 
intermetallic compounds that precipitate and, 
therefore is the most influential parameter 
controlling the resulting fixation device 
mechanical properties, corrosion performance, 
and age hardening affects. Surface finish quality 
has a significant effect on the corrosion and 
bone-implant contact of Mg alloy fixation 
devices.  
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